Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Diabetes and Metabolic Disorders|June 19, 2020
Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patientsYong Hoon Kim, Ae-Young Her, Seung-Woon Rha, et al.Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.American Heart Journal|April 3, 2026
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trialIn Tae Jin, Sang-Hyup Lee, Kyeong Ho Yun, et al.Lancet (London, England)|February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trialJeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.Korean Circulation Journal|May 30, 2015
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.Journal of Korean Medical Science|November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE studyUng Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.Korean Circulation Journal|August 5, 2015
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive PatientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.BMC Pharmacology & Toxicology|January 7, 2017
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemiaMoo-Yong Rhee, Taehoon Ahn, Kiyuk Chang, et al.The New England Journal of Medicine|November 10, 2025
Therapy for Atrial Fibrillation in Patients with Drug-Eluting StentsSeung-Jun Lee, Hee Tae Yu, Yong-Joon Lee, et al.Pageof 7